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transmission between the immigrant
and autochthonous population has
been frequently detected (8), likely
indicating a fairly high degree of
social permeability between the 2
groups. The transmission of Beijing
MTB from a person born in another
country to a person born in Spain
reported here seems to follow this
trend and raises concern about a
potential spread of Beijing MTB to
the autochthonous population. 
The isolate from the other Spanish
patient (patient 6) shared the genotype
of the strain described earlier in the
spread of Beijing genotype in Gran
Canaria (9); a Liberian was the first
case-patient. The patient from Spain
in our report had been imprisoned on
that island before her arrival in
Madrid. These data suggest another
way Beijing genotype can be import-
ed into Spain, which is different from
the South American route.
In summary, we describe TB
patients with Beijing genotype strains
in Madrid among patients from South
America. This geographic origin dif-
fers from the predominant Asian ori-
gin reported for TB cases in other
European countries caused by the
Beijing genotype. Our findings sug-
gest an alternate route of transmission
between South America and Europe
for the Beijing genotype. Furthermore,
the recent occurrence of this genotype
in a TB patient from Spain, who
shared an RFLP type with a South
American patient, suggests further
transmission of these strains into the
local community. Longitudinal studies
should monitor the potential impact
and establishment of these strains after
their introduction.
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H5N1 Avian
Influenza, Kampot
Province,
Cambodia
To the Editor: As a resident in
pediatrics with an interest in infec-
tious diseases, I was fascinated by the
range and scope of conditions I saw in
May and June of 2005 in local chil-
dren in Kampot Province, a mainly
rural area in southeastern Cambodia.
This province, near the Vietnamese
border, is the epicenter of H5N1 avian
influenza in Cambodia, with all 4
known human cases of the disease.
All of these documented human cases
have been fatal.
While the World Health
Organization and the Cambodian
Ministry of Health have engaged in
public education, the village-level
response to a pathogen of potential
global importance is evolving. As part
of my work in Cambodia, I made
numerous information-gathering vis-
its to villages in Kampot Province.
Though village elders and health
workers had often heard of the “bird
flu,” most of the villagers I spoke to
had not. Many persons did not know
whom to contact should their chickens
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or other birds die. Those who knew
about H5N1 influenza told me that,
without adequate compensation for
culling flocks, little incentive would
exist to report bird deaths. In a typical
village, chickens, ducks, and pigs
intermingled with each other and with
humans underneath or around homes
on stilts. General knowledge of infec-
tion control practices among villagers
was minimal.
The dissemination of information
into a rural, agricultural society such
as that in the southeast of Cambodia is
a difficult task. Many rural inhabitants
do not have televisions or radios and
may infrequently travel to larger
towns. Health workers from interna-
tional groups, nongovernmental
organizations, and the government are
often required to travel on foot or
motorbike through fields and forests to
reach and educate the population.
Government health workers lack the
personnel and resources to adequately
identify and investigate potential
cases, and Cambodia has substantially
fewer microbiology laboratories than
do neighboring Thailand and Vietnam.
Should a pandemic of avian
influenza occur, it will almost certain-
ly originate in Southeast Asia.
Cambodian and international health
organizations have recognized the
country’s potential key role in propa-
gation of an impending pandemic
agent. However, because of its history
and current economic state, Cambodia
is less able to respond to the avian
influenza threat than its neighbors. In
recognition of this fact, the World
Health Organization and the
Cambodian Ministry of Health have
stated that the prevention, control, and
identification of avian influenza are
national priorities. Additionally, inter-
national funds have been flowing into
Cambodia to assist with avian H5N1
influenza surveillance and case inves-
tigation. Much work remains to be
done; we hope that by combining
international resources and policy
with domestic expertise and effort,
Cambodia will mount a successful
response against this emerging threat.
Shaun K. Morris*
*University of Toronto, Toronto, Ontario,
Canada
Address for correspondence: Shaun K. Morris,
Department of Pediatrics, The Hospital for Sick
Children, The University of Toronto, 555
University Ave, Toronto, Ontario M5G1X8,
Canada; email: shaun.morris@utoronto.ca
Helicobacter 
pylori and Immuno-
compromised
Children
To the Editor: Helicobacter
pylori has been classified as a carcino-
genic pathogen. Its prevalence is high
in developing countries. Apart from
the known gastrointestinal pathologic
changes caused by this organism,
reports on the association between H.
pylori infection and extragastro-
intestinal diseases have been increas-
ing. Although impaired host immuni-
ty should be associated with a high
prevalence of this infection, a defini-
tive relationship has not been estab-
lished. We conducted a cross-section-
al study to determine the prevalence
of H. pylori infection in immunocom-
promised Thai children. 
The study was reviewed and
approved by the research ethic com-
mittee of Chiang Mai University.
From 2003 to 2004, a total of 60 chil-
dren <18 years of age, who received
corticosteroids, immunosuppressive
drugs, or both, were enrolled consec-
utively into this study. Patients who
had taken proton pump inhibitors and
antimicrobial drugs 2 weeks before
the study began were excluded. Stool
specimens were collected and imme-
diately stored at –20°C before analy-
sis with the H. pylori stool antigen test
(Meridian Bioscience Inc., Cincinnati,
OH, USA). Although no study has
validated this test in Thai children,
most studies report its high sensitivity
and specificity (>90%) (1). 
The children enrolled in the study
had a mean age of 7.9 years (range
0.5–16.6) and most were receiving
both corticosteroids and chemothera-
py (n = 36). Fourteen patients were
being treated exclusively with corti-
costeroids, and 10 patients were
receiving only chemotherapy. A total
of 17.4% of the children <5 years of
age had H. pylori infection, and the
overall prevalence was 20%.
Although we observed a relatively
high prevalence of infection in
patients with malignancy, particularly
leukemia, the trend did not reach sta-
tistical significance (Table).
In contrast to previous studies that
reported a low prevalence of infection
with H. pylori in patients with AIDS
(2) and leukemia (3), we demonstrated
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